202 related articles for article (PubMed ID: 27123741)
21. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
[TBL] [Abstract][Full Text] [Related]
22. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Gisselbrecht C; Lepage E; Molina T; Quesnel B; Fillet G; Lederlin P; Coiffier B; Tilly H; Gabarre J; Guilmin F; Hermine O; Reyes F;
J Clin Oncol; 2002 May; 20(10):2472-9. PubMed ID: 12011124
[TBL] [Abstract][Full Text] [Related]
23. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.
Hjermstad MJ; Knobel H; Brinch L; Fayers PM; Loge JH; Holte H; Kaasa S
Bone Marrow Transplant; 2004 Aug; 34(3):257-66. PubMed ID: 15170167
[TBL] [Abstract][Full Text] [Related]
25. High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: a study using patients as their own controls.
Vignot S; Mounier N; Larghero J; Brice P; Quero L; de Bazelaire C; Ertault M; Brière J; Madelaine I; Gisselbrecht C
Cancer; 2007 Jan; 109(1):60-7. PubMed ID: 17111421
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma.
Gulbrandsen MS; Nøding AS; Smeland KB; Eikeland SA; Kiserud CE; Hjermstad MJ; Fosså A
Leuk Lymphoma; 2023 Jun; 64(6):1139-1150. PubMed ID: 37144290
[TBL] [Abstract][Full Text] [Related]
27. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
[TBL] [Abstract][Full Text] [Related]
28. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation.
Hjermstad MJ; Loge JH; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
Bone Marrow Transplant; 1999 Dec; 24(11):1219-28. PubMed ID: 10642812
[TBL] [Abstract][Full Text] [Related]
29. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.
Kerhuel L; Amorim S; Azoulay E; Thiéblemont C; Canet E
Leuk Lymphoma; 2015; 56(11):3090-5. PubMed ID: 25813206
[TBL] [Abstract][Full Text] [Related]
31. Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma.
Dean HF; Cazaly A; Hurlock C; Borras J; Williams AP; Johnson PW; Davies AJ
Bone Marrow Transplant; 2012 Dec; 47(12):1545-51. PubMed ID: 22580768
[TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.
Kim HJ; Bang SM; Lee J; Kwon HC; Suh C; Kim HJ; Lee JH; Ryoo BY; Park YH; Kwon JM; Oh SY; Lee HR; Kim K; Jung CW; Park K; Kim WS
Bone Marrow Transplant; 2006 May; 37(9):819-24. PubMed ID: 16547486
[TBL] [Abstract][Full Text] [Related]
33. Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
Magyari F; Kósa K; Berecz R; Illés A; Miltényi Z; Simon Z; Illés Á
Health Qual Life Outcomes; 2017 Sep; 15(1):180. PubMed ID: 28927453
[TBL] [Abstract][Full Text] [Related]
34. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma.
Ingen-Housz-Oro S; Bachelez H; Verola O; Lebbé C; Marolleau JP; Hennequin C; Dubertret L; Morel P; Gisselbrecht C; Brice P
Bone Marrow Transplant; 2004 Mar; 33(6):629-34. PubMed ID: 14755323
[TBL] [Abstract][Full Text] [Related]
35. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Ahn JS; Yang DH; Jung SH; Chae YS; Sohn SK; Yhim HY; Kwak JY; Lee SR; Kim YK; Kim HJ; Lee JJ
Ann Hematol; 2013 Jun; 92(6):789-97. PubMed ID: 23358616
[TBL] [Abstract][Full Text] [Related]
36. Do male lymphoma survivors have impaired sexual function?
Kiserud CE; Schover LR; Dahl AA; Fosså A; Bjøro T; Loge JH; Holte H; Yuan Y; Fosså SD
J Clin Oncol; 2009 Dec; 27(35):6019-26. PubMed ID: 19858388
[TBL] [Abstract][Full Text] [Related]
37. Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age.
Takasaki H; Hashimoto C; Fujita A; Matsumoto K; Taguchi J; Kuwabara H; Yamazaki E; Koharazawa H; Fujita H; Fujisawa S; Ishii Y; Yamamoto W; Motomura S; Tomita N; Ishigatsubo Y; Sakai R
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):404-9. PubMed ID: 23763919
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Metzner B; Müller TH; Gebauer W; Casper J; Kraemer D; Rosien B; Schumann-Binarsch S; Thole R; Köhne CH; Dreyling M; Hoster E; Pott C
Ann Hematol; 2014 May; 93(5):803-10. PubMed ID: 24337447
[TBL] [Abstract][Full Text] [Related]
39. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
[TBL] [Abstract][Full Text] [Related]
40. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Kyriakou C; Canals C; Goldstone A; Caballero D; Metzner B; Kobbe G; Kolb HJ; Kienast J; Reimer P; Finke J; Oberg G; Hunter A; Theorin N; Sureda A; Schmitz N;
J Clin Oncol; 2008 Jan; 26(2):218-24. PubMed ID: 18182664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
